Lineage Cell Therapeutics
LCTX
LCTX
105 hedge funds and large institutions have $73.1M invested in Lineage Cell Therapeutics in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 28 reducing their positions, and 11 closing their positions.
Holders
105
Holders Change
+4
Holders Change %
+3.96%
% of All Funds
1.82%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
16
Increased
17
Reduced
28
Closed
11
Calls
$173K
Puts
$2K
Net Calls
+$171K
Net Calls Change
-$80K